Related references
Note: Only part of the references are listed.Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice
Seung Kew Yoon et al.
LIVER INTERNATIONAL (2015)
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
Masashi Iwamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Advances and Challenges in the Development of Therapeutic DNA Vaccines Against Hepatitis B Virus Infection
Lucyna Cova
CURRENT GENE THERAPY (2014)
Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)
Koichi Watashi et al.
HEPATOLOGY (2014)
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
Shirin Nkongolo et al.
JOURNAL OF HEPATOLOGY (2014)
Immunological and Antiviral Responses After Therapeutic DNA Immunization in Chronic Hepatitis B Patients Efficiently Treated by Analogues
O. Godon et al.
MOLECULAR THERAPY (2014)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection
Jia Liu et al.
PLOS PATHOGENS (2014)
Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly
Guoyi Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity
Yuan Hu et al.
ANTIVIRAL RESEARCH (2013)
Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes
Julie Lucifora et al.
ANTIVIRAL RESEARCH (2013)
Long-term Results of Treatment with Nucleoside and Nucleotide Analogues (Entecavir and Tenofovir) for Chronic Hepatitis B
Tarik Asselah et al.
CLINICS IN LIVER DISEASE (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
752 THERAPEUTIC VACCINATION FOR CHRONIC HEPATITIS B (CHB) USING HETEROLOGOUS PROTEIN PRIME/VECTOR BOOST VACCINATION SCHEME
C. Jäger et al.
JOURNAL OF HEPATOLOGY (2013)
A PHASE III CLINICAL TRIAL WITH A NASAL VACCINE CONTAINING BOTH HBsAg AND HBcAg IN PATIENTS WITH CHRONIC HEPATITIS B
M. A. Mahtab et al.
JOURNAL OF HEPATOLOGY (2013)
A CLINICAL TRIAL ON ANTI-HBV-DC VACCINE COMBINED WITH LAMIVUDINE AND THYMOSIN-α1 IN THE HBeAg POSITIVE PATIENTS OF CHRONIC HEPATITIS B VIRUS INFECTION
B. -F. Wu et al.
JOURNAL OF HEPATOLOGY (2013)
Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
Dao-Zhen Xu et al.
JOURNAL OF HEPATOLOGY (2013)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
Tassilo Volz et al.
JOURNAL OF HEPATOLOGY (2013)
Regulation of Hepatitis B Virus Infection by Rab5, Rab7, and the Endolysosomal Compartment
Alina Macovei et al.
JOURNAL OF VIROLOGY (2013)
Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and lLong-Term-siRNA Treatment
Guang-Li Ren et al.
PLOS ONE (2013)
A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice
Pascale Buchmann et al.
VACCINE (2013)
Combination of DNA Prime - Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model
Anna D. Kosinska et al.
PLOS PATHOGENS (2013)
Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus
Sheikh Mohammad Fazle Akbar et al.
ANTIVIRAL RESEARCH (2012)
In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations
Xue-Yan Wang et al.
ANTIVIRAL THERAPY (2012)
Serum Hepatitis B Surface Antigen Levels and Their Utility as a Predictor of Sustained Virological Response After Antiviral Treatment
Peter Karayiannis
HEPATITIS MONTHLY (2012)
Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection
Jeremie Martinet et al.
HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy
F. -Q. Yang et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
Bruno Sainz et al.
NATURE MEDICINE (2012)
Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp
Mohamed M. S. Farag et al.
VACCINE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Partially Randomized, Non-Blinded Trial of DNA and MVA Therapeutic Vaccines Based on Hepatitis B Virus Surface Protein for Chronic HBV Infection
James S. Cavenaugh et al.
PLOS ONE (2011)
Antiviral Activity of Bay 41-4109 on Hepatitis B Virus in Humanized Alb-uPA/SCID Mice
Nicolas Brezillon et al.
PLOS ONE (2011)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
HIV-1 Reverse Transcriptase Can Simultaneously Engage Its DNA/RNA Substrate at Both DNA Polymerase and RNase H Active Sites: Implications for RNase H Inhibition
Greg L. Beilhartz et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Hepatitis B virus-cell interactions and pathogenesis
David H. Nguyen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly
Guo-Yi Wu et al.
JOURNAL OF CHEMOTHERAPY (2008)
HBX binds in vivo on the HBV minichromosome, modifies the epigenetic regulation of ccc-DNA function and potentiates HBV replication
L. Belloni et al.
JOURNAL OF HEPATOLOGY (2008)
Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones
T Pollicino et al.
GASTROENTEROLOGY (2006)
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein
P Gripon et al.
JOURNAL OF VIROLOGY (2005)
Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones
SR Budihas et al.
NUCLEIC ACIDS RESEARCH (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model
O Weber et al.
ANTIVIRAL RESEARCH (2002)
CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-Transgenic mice
E Malanchère-Brès et al.
JOURNAL OF VIROLOGY (2001)
Efficacy and limitations of a specific immunotherapy in chronic hepatitis B
S Pol et al.
JOURNAL OF HEPATOLOGY (2001)
CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans
HL Davis et al.
VACCINE (2000)
Hepatitis B virus biology
C Seeger et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)
Share Paper
